Potential Alzheimer’s disease drug targets identified through microglial biology research

IF 6 2区 医学 Q1 PHARMACOLOGY & PHARMACY Expert Opinion on Drug Discovery Pub Date : 2024-04-08 DOI:10.1080/17460441.2024.2335210
Izabela Lepiarz-Raba, Taufik Hidayat, Anthony J. Hannan, Ali Jawaid
{"title":"Potential Alzheimer’s disease drug targets identified through microglial biology research","authors":"Izabela Lepiarz-Raba, Taufik Hidayat, Anthony J. Hannan, Ali Jawaid","doi":"10.1080/17460441.2024.2335210","DOIUrl":null,"url":null,"abstract":"Microglia, the primary immune cells in the brain, play multifaceted roles in Alzheimer’s disease (AD). Microglia can potentially mitigate the pathological progression of AD by clearing amyloid beta...","PeriodicalId":12267,"journal":{"name":"Expert Opinion on Drug Discovery","volume":null,"pages":null},"PeriodicalIF":6.0000,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Drug Discovery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17460441.2024.2335210","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Microglia, the primary immune cells in the brain, play multifaceted roles in Alzheimer’s disease (AD). Microglia can potentially mitigate the pathological progression of AD by clearing amyloid beta...
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过小胶质细胞生物学研究确定阿尔茨海默病潜在药物靶点
小胶质细胞是大脑中的主要免疫细胞,在阿尔茨海默病(AD)中发挥着多方面的作用。小胶质细胞可以通过清除淀粉样蛋白β来缓解阿尔茨海默病的病理进展...
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.20
自引率
1.60%
发文量
78
审稿时长
6-12 weeks
期刊介绍: Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.
期刊最新文献
Correction. Data-centric challenges with the application and adoption of artificial intelligence for drug discovery. Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system. Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges. Targeting AGAT gene expression - a drug screening approach for the treatment of GAMT deficiency.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1